Olmesartan Medoxomil – Watch for These Side Effects

FDA is warning that the blood pressure drug Olmesartan Medoxomil marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics can cause intestinal problems known as sprue-like enteropathy. Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. FDA has approved changes to the labels of these drugs to include this concern. Sprue-like enteropathy has not been detected with ARB drugs other than olmesartan

via Safety Alerts for Human Medical Products > Olmesartan Medoxomil: Drug Safety Communication – Label Changes To Include Intestinal Problems Sprue-Like Enteropathy.

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s